Complete response of metastatic papillary renal cell carcinoma with inferior vena cava tumor thrombus to nivolumab plus cabozantinib.
Michikata HayashidaYuji MiuraTakeshi YamaguchiMakoto TanakaTaro YamanakaKohji TakemuraSuguru OkaKazushige SakaguchiShinji ItoShinji UrakamiPublished in: IJU case reports (2023)
Nivolumab plus cabozantinib has effectiveness for metastatic papillary renal cell carcinoma with inferior vena cava tumor thrombus.